InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（12 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
12
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Farnum Rhonda, Directrice Exécutive et Responsable des Affaires Médicales. Officer active across 1 company, notably Theravance Biopharma, Inc.. Aggregated, 35 disclosures have been recorded. Breakdown: 0 buy · 12 sells. Total volume traded: €684k. History available since 14 December 2021. The latest transaction was filed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Farnum Rhonda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报35 总计
5,667 股@ US$16.950.011% mcap3.3% 占其流量Ordinary SharesSEC:0001898490-26-000012:0
18,750 股0Ordinary SharesSEC:0001898490-26-000006:0
7,767 股@ US$13.91635.3% 占其流量Ordinary SharesSEC:0001898490-26-000004:0
13,929 股@ US$19.669.8% 占其流量Ordinary SharesSEC:0001898490-26-000002:0
7,767 股@ US$18.74995.8% 占其流量Ordinary SharesSEC:0001898490-25-000008:0
9,060 股@ US$17.907.0% 占其流量Ordinary SharesSEC:0001898490-25-000006:0
9,096 股@ US$13.395.6% 占其流量Ordinary SharesSEC:0001415889-25-022794:0
682 股@ US$11.39270.4% 占其流量Ordinary SharesSEC:0001415889-25-019869:0
24,000 股@ US$11.0013.8% 占其流量Ordinary SharesSEC:0001415889-25-015642:0
9,120 股@ US$9.455.3% 占其流量Ordinary SharesSEC:0001415889-25-014257:0
4,000 股@ US$9.002.2% 占其流量Ordinary SharesSEC:0001415889-25-011227:0
75,000 股0Ordinary SharesSEC:0001415889-25-006668:0
5,283 股0Ordinary SharesSEC:0001415889-25-005347:0
4,000 股@ US$9.002.4% 占其流量Ordinary SharesSEC:0001415889-25-001957:0
9,178 股@ US$9.976.0% 占其流量Ordinary SharesSEC:0001415889-24-027564:0
4,000 股@ US$9.002.3% 占其流量Ordinary SharesSEC:0001415889-24-026766:0
9,222 股@ US$8.224.7% 占其流量Ordinary SharesSEC:0001415889-24-022084:0
4,000 股@ US$9.002.3% 占其流量Ordinary SharesSEC:0001415889-24-019534:0
9,268 股@ US$9.105.4% 占其流量Ordinary SharesSEC:0001415889-24-014133:0
37,500 股0Ordinary SharesSEC:0001415889-24-010320:0
18,219 股@ US$8.9210.5% 占其流量Ordinary SharesSEC:0001415889-24-004958:0
7,982 股@ US$10.375.3% 占其流量Ordinary SharesSEC:0001415889-23-015446:0
1,807 股@ US$9.471.1% 占其流量Ordinary SharesSEC:0001415889-23-012621:0
10,460 股@ US$9.706.5% 占其流量Ordinary SharesSEC:0001415889-23-012510:0
1,790 股@ US$11.131.3% 占其流量Ordinary SharesSEC:0001415889-23-009636:0
35 条申报中的 25 条
About Farnum Rhonda
Farnum Rhonda is Directrice Exécutive et Responsable des Affaires Médicales at Theravance Biopharma, Inc., where her listed function is SVP, COMM & MEDICAL AFFAIRS. She has 34 filings in total, and across the recent filings we hold, buys are 0 EUR and sells are 683914 EUR, with filings dated from 2021-12-16 to 2026-04-03; the most common transaction nature is Retenue fiscale.
